Cargando…

Rosuvastatin as forthcoming antibiotic or as adjuvant additive agent: In vitro novel antibacterial study

INTRODUCTION: Rosuvastatin is a lipid-lowering agent that inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase leading to a reduction of cholesterol biosynthesis. Many studies have shown an association between statins use and the reduction of sepsis. The aim of the present study was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Kuraishy, Hayder M., Al-Gareeb, Ali I., Al-Buhadily, Ali K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052819/
https://www.ncbi.nlm.nih.gov/pubmed/30078961
http://dx.doi.org/10.4103/JLP.JLP_170_17